Wordt geladen...
Biological Drugs in Guillain-Barré Syndrome: An Update
BACKGROUND: Guillain-Barré Syndrome (GBS) is currently considered the most common global cause of acute flaccid paralysis. Currently, standard therapy for Guillain-Barré Syndrome includes intravenous immunoglobulin or plasma exchange. Despite medical advances regarding these treatments, many treated...
Bewaard in:
| Gepubliceerd in: | Curr Neuropharmacol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Bentham Science Publishers
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652014/ https://ncbi.nlm.nih.gov/pubmed/27964705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666161213114904 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|